Alfasigma Wins EU Approval for Filgotinib in Axial Spondyloarthritis
Alfasigma has received European Commission approval to expand the use of filgotinib for adults with active axial…
Trending
- Alfasigma Wins EU Approval for Filgotinib in Axial Spondyloarthritis
- Boehringer Ingelheim Signs $7B Oncology Deal with SBP Group
- Evommune Licenses Hinova’s EVO570 in $1.1B Deal for Autoimmune Diseases
- T-Therapeutics Raises $133M to Advance Cancer and Autoimmune Therapies
- Brains Bioceutical Announces $750M Deal for Proposed Nasdaq Listing
- Lonza to Acquire Five US Manufacturing Sites from Merck KGaA
- FDA Accepts uniQure’s Gene Therapy Application for Huntington’s Disease
- Circular Genomics Partners with PharmatrophiX on Alzheimer’s Biomarkers
- Fresenius Partners with WuXi Biologics to Expand Biosimilar Pipeline
- Bavarian Nordic Wins Four-Year UK Vaccine Supply Contract
Top Headlines
Boehringer Ingelheim Signs $7B Oncology Deal with SBP Group
Boehringer Ingelheim has entered into a major oncology partnership with China's Sino Biopharmaceutical Limited (SBP…
Evommune Licenses Hinova’s EVO570 in $1.1B Deal for Autoimmune Diseases
Evommune, Inc. has entered into an exclusive licensing agreement with China's Hinova Pharmaceuticals to develop and…
T-Therapeutics Raises $133M to Advance Cancer and Autoimmune Therapies
T-Therapeutics, a biotechnology company based in Cambridge, UK, has raised $133 million in an oversubscribed Series…
Brains Bioceutical Announces $750M Deal for Proposed Nasdaq Listing
Brains Bioceutical Corp. has entered into a definitive business combination agreement with Armada Acquisition Corp.…
Lonza to Acquire Five US Manufacturing Sites from Merck KGaA
Lonza, a Switzerland-based contract development and manufacturing organization (CDMO), has signed an agreement to…
Featured Event
Clinical Trials
Boehringer Starts Phase III Trial of Verducatib for COPD
Boehringer Ingelheim has registered a new Phase III clinical trial to evaluate verducatib, an experimental oral medicine for people living with…
EyePoint’s DURAVYU Fails Main Endpoint in Phase 3 Wet AMD Trial
EyePoint, Inc. (NASDAQ: EYPT) has announced topline results from its LUCIA Phase 3 clinical trial evaluating DURAVYU (vorolanib intravitreal insert)…
Roche Wins FDA Approval for Enspryng in Thyroid Eye Disease
Roche has received approval from the U.S. Food and Drug Administration (FDA) for Enspryng (satralizumab) to treat adults with thyroid eye disease…
Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial
AstraZeneca and Ionis Pharmaceuticals have announced that their Phase III CARDIO-TTRansform trial evaluating Wainua (eplontersen) in patients with…
Boehringer Advances Phase III Cancer Precision Medicine Trials
Boehringer Ingelheim has announced the launch of three Phase III clinical trials aimed at advancing precision oncology for patients with some of the…
uniQure Reports Early Promise for Epilepsy Gene Therapy
uniQure has reported encouraging early clinical results from its experimental gene therapy AMT-260, offering new hope for patients living with…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Appian and PSI CRO Partner to Bring AI Into Clinical Trials
Appian and PSI CRO have formed a strategic partnership to use artificial intelligence (AI) and automation to…
Pathos AI Partners with BMS and Tempus to Advance Alzheimer’s Drug Research
Pathos AI has announced strategic collaborations with Bristol Myers Squibb (BMS) and Tempus AI to use artificial…
Drug Research
Big Pharma Turns to AI to Find New Drugs
Big pharma is investing in AI drug discovery through major partnerships with biotech and technology companies,…
AstraZeneca Invests $2B in Summit Therapeutics for Cancer Research
AstraZeneca has agreed to invest $2 billion in Summit Therapeutics to support the development of ivonescimab and…
Sentynl, Mereo Partner to Advance Oral AATD Lung Disease Therapy
Sentynl Therapeutics, a U.S.-based biopharmaceutical company and wholly owned subsidiary of Zydus Lifesciences, has…
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
UK Streamlines Drug Approvals to Accelerate Patient Access
The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care…
Manufacturing
Fresenius Partners with WuXi Biologics to Expand Biosimilar Pipeline
Fresenius SE & Co. KGaA has entered into an exclusive development agreement with WuXi Biologics to expand its…
SK pharmteco Invests $200M to Expand U.S. Drug Manufacturing
SK pharmteco has announced a five-year investment of more than $200 million to expand and upgrade its development…
Varda Raises $251M to Scale Space-Based Pharmaceutical Manufacturing
Varda Space Industries has raised $251 million in a Series D financing round to expand its work in space-based…
Genentech Plans $750 Million Device Manufacturing Facility in Oregon
Genentech, a member of the Roche Group, plans to invest approximately $750 million to build a new device…
Fujifilm and Taiho Partner on Next-Generation ADC Manufacturing
FUJIFILM Corporation and Taiho Pharmaceutical have formed a strategic partnership to advance manufacturing…
Cellares and SonomaBio Partner on Automated Treg Cell Therapy Manufacturing
Cellares and Sonoma Biotherapeutics have announced a new collaboration to automate the manufacturing of…
Cellares, TScan Partner on Automated TSC-101 Manufacturing
Cellares and TScan Therapeutics have entered into a strategic agreement to evaluate automated clinical…
Fujifilm Expands Stem Cell Manufacturing in Wisconsin
FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development…
Diseases
FDA Accepts uniQure’s Gene Therapy Application for Huntington’s Disease
uniQure N.V. has received an important regulatory milestone in its effort to develop a gene therapy for…
Circular Genomics Partners with PharmatrophiX on Alzheimer’s Biomarkers
Circular Genomics and PharmatrophiX have announced a strategic collaboration to use blood-based circular RNA…
Estuary Biotherapeutics Launches with $103 Million for Kidney Gene Therapies
Estuary Biotherapeutics has launched with $103 million in committed financing to develop targeted gene therapies…
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
